Search fresh public links, source activity, and post angles for #Biocon.
Fresh curated links around #Biocon are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Biocon: Nuvama said Q4FY26 growth moderated as Biocon upgraded facilities to scale up capacity in response to anticipated demand in the US and Europe.
Synopsis: Biocon Limited received Health Canada approval for Bosayaâ„¢ and Vevzuoâ„¢, denosumab biosimilars for osteoporosis and cancer-related bone conditions, expanding global re...
Synopsis: Biocon Limited received Health Canada approval for Bosayaâ„¢ and Vevzuoâ„¢, denosumab biosimilars for osteoporosis and cancer-related bone conditions, expanding global re...
नई दिल्ली: भारत की मशहूर Biotech Entrepreneur Kiran Mazumdar-Shaw ने अपनी कंपनी के भविष्य को लेकर बड़ा कदम उठाया है। उन्होंने अपनी भतीजी Claire Mazumdar को अपना उत्तराधिकारी चुना ह...
Claire Mazumdar, 37 years of age, currently heads Bicara Therapeutics as its founder and CEO. The firm, which was incubated by Biocon and later listed on NASDAQ, went public in 202...
Other pharma stocks, including Wockhardt Ltd, Lupin Ltd, Divi's Laboratories Ltd, Zydus Lifesciences Ltd, Torrent Pharmaceuticals Ltd, JB Chemicals & Pharmaceuticals Ltd, Manki...
On April 2, 2026, Biocon filed a petition for post-grant review (“PGR”) challenging Regeneron’s U.S. Patent No. 12,168,036 (“the ’036 patent”), which is directed to methods for tre...
The decline was largely attributed to exceptional costs, including employee-related expenses, and the ongoing impact of destocking by a key biologics client linked to Librela.
The decline was largely attributed to exceptional costs, including employee-related expenses, and the ongoing impact of destocking by a key biologics client linked to Librela.
Revenue rises 3% to Rs 3,739 crore; margins contract to 25% even as Q4 shows sequential recovery
On April 7, 2026, Biocon announced the U.S. commercial launch of Bosaya™ / Aukelso™ (denosumab-kyqq), biosimilars of Amgen’s Prolia® / Xgeva® (denosumab)....By: Venable L...
BridgeBio Anonymous (not verified) Mon, 05/11/2026 - 11:23 field_thread_url https://cafepharma.com/boards/threads/bridgebio.698762/ boar...
Beigene Anonymous (not verified) Mon, 05/25/2026 - 11:38 field_thread_url https://cafepharma.com/boards/threads/beigene.637588/ board na...
Synopsis: Indegene Limited is revolutionising life sciences by integrating generative AI into its domain-led operating model. By achieving record FY26 revenues of Rs.3,510 crore an...
Beigene Anonymous (not verified) Thu, 04/30/2026 - 14:18 field_thread_url https://cafepharma.com/boards/threads/beigene.637588/ board na...
This is the first time such huge investments are being made. The Indian pharmaceutical industry has grown from small companies into multinational corporations. Out of the top 20 gl...
India’s largest biotech startup competition returns with Rs 20 crore prize pool, widening push to back science-led innovation beyond metro hubs.
Synopsis: Expanding a CMO relationship first disclosed in May 2024, Aurobindo Pharma’s subsidiary TheraNym Biologics has signed an additional product schedule with Merck Sharp &...
Axis Direct said that V2 Retail has regained the buying momentum around the 200-day SMA support zone of Rs 204 on the daily charts, which remains a crucial support level.
Synopsis: Dr. Reddy’s Laboratories has received a strategic boost after its partner secured Health Canada approval for Semaglutide Injection, strengthening its position in the high...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.